Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Vekris

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Critical Reviews in Oncology/Hematology|August 28, 2004
Predicting drug response based on gene expressionJacques Robert, Antoine Vekris, Philippe Pourquier, et al.
Biochemical and Biophysical Research Communications|August 30, 2002
Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivoJean-Rémi Bertrand, Mireille Pottier, Antoine Vekris, et al.
Cancer Research|January 20, 2004
Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico researchAntoine Vekris, Delphine Meynard, Marie-Christine Haaz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administrationJoanna Mikita, Nadège Dubourdieu-Cassagno, Mathilde Sa Deloire, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|August 28, 2004
Predicting drug response based on gene expressionJacques Robert, Antoine Vekris, Philippe Pourquier, et al.
Biochemical and Biophysical Research Communications|August 30, 2002
Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivoJean-Rémi Bertrand, Mireille Pottier, Antoine Vekris, et al.
Cancer Research|January 20, 2004
Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico researchAntoine Vekris, Delphine Meynard, Marie-Christine Haaz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administrationJoanna Mikita, Nadège Dubourdieu-Cassagno, Mathilde Sa Deloire, et al.
Pageof 1